Due Diligence

The pharmaceutical industry is a fast changing environment and the due diligence (DD) process is of equally high financial importance for seller (our-licensing) and buyer (in-licensing). With consultants experienced on both sides, we can assist you in the evaluation of a potential opportunity as well as in the preparation of a comprehensive package for the successful sale of your technology or project.  

We Provide Due Diligence Services for:

In-Licensing

• Target evaluation

• Preliminary DD evaluation (identification of early flags)

• Deep-fact finding in eRoom

•  Formal face-to-face DD for early projects or clinical candidates

• Identification of key safety issues and risk assessment

• Assessment of regulatory dossier and evaluation of current and  planned regulatory strategies

• Evaluation of CMC information to determine current status of manufacturing feasibility and future development needs 

Out-Licensing

• Identification of potential buyers

• Organization of DD meetings

• Preparation of a due diligence package

• Identification of key missing data

• Preparation of DD presentations

• Evaluation of current regulatory dossier and gap analysis to assess regulatory hurdles which may impact project worth